This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción IMV
IMV Inc. operates as a clinical-stage immuno-oncology company.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de IMV Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.12 |
| 52 Week High | CA$13.10 |
| 52 Week Low | CA$0.62 |
| Beta | 1.38 |
| 1 Month Change | 0% |
| 3 Month Change | 60.00% |
| 1 Year Change | -89.72% |
| 3 Year Change | -96.97% |
| 5 Year Change | -98.41% |
| Change since IPO | -96.96% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| IMV | CA Biotechs | Mercado CA | |
|---|---|---|---|
| 7D | 0% | -3.3% | -0.1% |
| 1Y | -89.7% | -38.7% | 6.2% |
Rentabilidad vs. Industria: IMV underperformed the Canadian Biotechs industry which returned 27.7% over the past year.
Rentabilidad vs. Mercado: IMV underperformed the Canadian Market which returned -5.1% over the past year.
Volatilidad de los precios
| IMV volatility | |
|---|---|
| IMV Average Weekly Movement | 15.5% |
| Biotechs Industry Average Movement | 11.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Precio estable de las acciones: IMV's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: IMV's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 63 | Andrew Hall | www.imv-inc.com |
Resumen de fundamentos de IMV Inc.
| Estadísticas fundamentales de IMV | |
|---|---|
| Capitalización bursátil | CA$13.12m |
| Beneficios(TTM) | -CA$50.71m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-0.3x
Ratio precio-beneficio (PE)¿Está IMV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de IMV | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$23.28m |
| Beneficio bruto | -US$23.28m |
| Otros gastos | US$14.71m |
| Beneficios | -US$37.99m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -3.24 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | -415.9% |
¿Cómo se ha desempeñado IMV a largo plazo?
Ver rendimiento histórico y comparativa